A comprehensive approach incorporating additional cognitive impairment biomarkers such as neurofilament light chain, various tau proteins, APOE, Aβ, and the autophagy marker molecule LC3 is essential when utilizing Foxo3a as a diagnostic tool. This evidence concerns the gene FOXO3 and Cognitive impairment.